NEW DATA: 1. Critical #CHDs are lifelong dzs & carry a longer burden of care than common CV dzs- on average six of the cCHDs have ~ 14x higher lifetime burden of medical costs than congestive heart failure (CHF), w/ lifetime indirect costs ~23X more. additionalventures.org/wp-content/upl…

Thanks 🙏 Dr. Robert Elder and Yale Congenital Cardiology for the opportunity to present on Fontan and the #FORCE of collaboration. The future is bright as we work together to improve outcomes for patients with single ventricle 🫀 🙏Rahul Rathod Additional Ventures UPMC Heart and Vascular Institute UPMC Physician Resources

Looking forward to this outstanding panel on creative funding approaches to support pediatric cardiovascular medical devices for #CHD! Hosted by @childrensnatl CobiCure JLABS featuring our own Kirstie Keller, PhD

New work from Liming Pei & team using single-cell multiomics to uncover mechanisms of #Fontan associated liver disease #FALD x.com/penncvi/status…

Wow! Great progress - looking forward to working together to use these data, our shared experience, to advance understanding & care for single ventricle heart disease! #Fontan Tom Glenn Kiona Allen Kurt Schumacher Rahul Rathod Dr. Nadine Kasparian Additional Ventures Congenital Heart Alliance of Cincinnati

🧵 The numbers are shocking but not surprising: It costs almost $50,000/year to have complex congenital heart disease, per a report from Additional Ventures. I spoke to the report’s authors and highlighted the key findings. Read more 👉 bit.ly/chdcosts #CHD #CHDAwareness

Stellar work from #AVCIA Catalyst Awardee Sanjeev Ranade presenting at Weinstein Cardiovascular Conference this week 👏 Love to see our awardees in action! x.com/benoitbruneau/…

We're proud to support Weinstein Cardiovascular Conference and the critical role of cardiac #devbio in furthering our understanding of disease pathogenesis. Without a full picture of how a healthy heart develops, causes of #singleventricle remain incompletely understood! x.com/weinsteinconf/…

Congratulations, hananeh fonoudi! Thrilled to see #AVCIA Catalyst Awardee Hananeh present her #postdoc work @Weinsteinconf #WeinsteinCVD2024! x.com/hfonoudi/statu…

Congratulations, Diana Fulmer! Such fun to catch up with our awardees Weinstein Cardiovascular Conference this past week! x.com/dianabfulmer/s…

Stoked to share our latest #preprint: "#SingleCell Transcriptional Perturbome in #Pluripotent Stem Cell Models", made in Università di Torino & MendjanLab IMBA w/ support of Armenise Harvard Foundation, Additional Ventures & European Research Council (ERC). Sneak peek SSRN @cellpressnews papers.ssrn.com/sol3/papers.cf… 1/6

OUR LATEST Wellbeing Among Children & Adolescents with Fontan Physiology Kate Marshall Susan Woolfenden Dr. David Winlaw Yves d'Udekem ANZ Fontan Community FON NPCQIC Cardiac Neurodevelopmental Outcome Collaborative Cincinnati Children’s Research Cincinnati Children's Heart Institute Sydney Children's Hospitals Network JournalofPediatrics #Fontan #CHD #heartdisease jpeds.com/article/S0022-…

Congratulations to Wensi Wu for her publication in Small Methods on a PINN-based approach to determine the microscopic structure and elasticity of tissue from images. Additional Ventures Penn Bioengineering Mechanical Engineering and Applied Mechanics, Penn pubmed.ncbi.nlm.nih.gov/39091065/

Together with American Heart Association, we are proud to present our Collaborative Science in #SingleVentricle Heart Disease Program awardees! Proposals from 5 outstanding research teams were selected for funding, for a total investment of over $13M. Read more: additionalventures.org/news/announcin…

Been out for a few months, but worth a read from Additional Ventures - an Ex Summary on the Economic Burden of #CHD on the patient & family. In need for a thoughtful look with policy makers, improve funding & research. ACHA American College of Cardiology additionalventures.org/wp-content/upl…

.Children's National Hospital 🏥 & Additional Ventures partner for #pediatriccardiology devices: hubs.li/Q02LZdX-0

We are honored for the results of Additional Venture SVRF proposal selection. LEAFLET study will gather investigators from Bologna, Padova, Boston and Brussels to further dissect lymphatic disease in FC. Additional Ventures Fred Wu, MD 🫀 吳明杰 Anne Valente additionalventures.org/news/svrf-2024…

@additionalvent is looking for patient & family stories to share at its Single Ventricle Investigators Meeting for single ventricle heart disease researchers this fall. If you want to participate, you can share a photo and a bit about yourself/child here: buff.ly/474m4AK

Breaking news: we've been selected as a spoke of the Investor Catalyst Hub network! Thrilled to join this nationwide ARPA-H network dedicated to accelerating groundbreaking biomedical advances. Learn more: ow.ly/w1QO50TfKAs #ARPAH #ARPANETH #InvestorCatalystHub

We're thrilled to partner with AHA Science to support 5 outstanding teams through the Collaborative Science Awards! These teams will address underlying biological mechanisms & clinical sequelae of #singleventricle #CHD More info: additionalventures.org/news/announcin… x.com/ahascience/sta…